地塞米松联合氟哌利多预防腹腔镜胆囊切除术后恶心、呕吐

    Dexamethasone and droperidol in prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy

    • 摘要: 目的:探讨地塞米松联合氟哌利多预防腹腔镜胆囊切除(LC)术后恶心呕吐的效果。方法:180例ASAⅠ~Ⅱ级LC术患者,随机分成3组,各60例,A组术前静脉注射生理盐水10 ml,B组、C组术前分别静脉注射地塞米松10 mg、地塞米松10mg和氟哌利多20μg/kg,观察术后48 h患者的恶心、呕吐情况。结果:A组恶心、呕吐的发生率为68.3%,B组、C组恶心呕吐的发生率分别为26.7%和8.3%,各组间比较差异有统计学意义(P<0.005)。结论:地塞米松复合小剂量氟哌利多能减少术后恶心、呕吐。

       

      Abstract: Objective: To investigate the effect of dexamthasone and droperidol in prevention of postoperative nausea and vomiting(PONV) after laparoscopic cholecystectomy(LC).Methods: One hundred and eighty ASA physical statusⅠor Ⅱpatients were randomized into three groups.Group A(n=60):Normal saline 10 ml was administered intra venous before surgery.Group B(n=60):dexamethasone 10 mg and Group C(test group,n=60):dexamethasone 10 mg and droperidol 20 μg/kg were administered intra venous before surgery.The occurrence of PONV was recorded and assessed during 48 h after the surgery.Results: The incidence of PONV in group A was 68.3%,group B and group C were 26.7% and 8.3% respectively.There were significant difference between group A and Group B,group A and group C,and Group B and group C(P<0.005).Conclusions: Dexamethasone and the low-dose droperidol is better than dexamethasone alone and placebo in prevention of PONV after LC.

       

    /

    返回文章
    返回